2015, Number 1-2
<< Back Next >>
Cir Gen 2015; 37 (1-2)
Neuroischemic diabetic foot treated with ozone. Consequences of treatment
Bladinieres-Camara JE, Uhthoff-Brito S, Alcalá-Duran R, Anaya-Prado R, Lara-Ramírez EE
Language: Spanish
References: 8
Page: 44-48
PDF size: 671.17 Kb.
ABSTRACT
The beneficial effects of ozone are associated with an improvement in the health status, so much that it is being used as a medical therapy in many diseases. In this paper, a clinical case is presented of a patient with diabetic foot with clinical characteristics of neuroischemia and who was previously treated with ozone therapy.
REFERENCES
Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006; 37: 425-435.
Martínez-Sánchez G, Al-Dalain SM, Menéndez S, Re L, Giuliani A, Candelario-Jalil E, et al. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005; 523: 151-161.
American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003; 26: 3333-3341.
Mutluoglu M, Karabacak E, Karagöz H, Uzun G, Ay H. Topical ozone and chronic wounds: improper use of therapeutic tools may delay wound healing. N Am J Med Sci. 2012; 4: 615-616.
Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006; 47: 921-929.
Di Paolo N, Bocci V, Salvo DP, Palasciano G, Biagioli M, Meini S, et al. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. Int J Artif Organs. 2005; 28: 1039-1050.
Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med Gas Res. 2011; 1: 29.
Coppola A, Coppola L, Luongo C, Arciello A, Cacciapuoti F, Lama D, et al. Ozonized autohemotransfusion does not affect arterial vasodilation in patients with peripheral arterial disease. Int J Angiol. 2007; 16: 7-11.
Full text
10.35366/63554